Emily S. Andrew

Emily Andrew practices at Central San Diego Surgery Center Inc. in San Diego, California.

Emily Andrew's NPI, 1861961369, was assigned on November 14, 2018.

Emily Andrew's primary practice is Central San Diego Surgery Center Inc., at 4060 4th Ave, San Diego, CA 92103 in San Diego County. The practice phone is (619) 299-7467.

Emily Andrew's primary practice is Central San Diego Surgery Center Inc. in San Diego, California. The medical group on file is San Diego Gastroenterology Medical Associates. Dmand AI also links Emily Andrew to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Emily Andrew practices. Vendor and product names are available with a free account.

Physician assistant is Emily Andrew's primary specialty in the NPI Registry, under taxonomy code 363A00000X.

Dmand AI lists acute gastroduodenitis and gastroenteritis among the conditions Emily Andrew treats.

CMS data shows 104 Medicare services from Emily Andrew across 2 procedure codes in 2024, all of them office visits, for 111 Medicare patients. Medicare paid $9,547 for them. Every service was in an office.

CMS counts 111 Medicare patients who saw Emily Andrew in 2024. The largest group is 65 to 74, with 54 patients. 74% of them have high cholesterol, and 65% have high blood pressure. 22% are also on Medicaid. Their average risk score is 1.17, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Emily Andrew's median patient age at 63, with 54% women.

In 2024, Emily Andrew wrote 491 Medicare Part D claims for 195 patients. 76% of them were for generic drugs. CMS names the drug for 395 of them, across 7 drugs with 11 or more claims each, at $85,724 in total drug cost.

Emily Andrew accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 138 general payments to Emily Andrew from 21 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $664.